Vontobel Holding’s BioNTech BNTX Stock Holding History

Vontobel Holding’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Buy	+18,500	New	+$1.74M	0.01%	664
2026 Q1	–	Sell	-3,600	Closed	-$343K	–	1234
2025 Q4	$343K	Buy	+3,600	New	+$363K	﹤0.01%	1125
2025 Q3	–	Sell	-1,200	Closed	-$128K	–	1357
2025 Q2	$128K	Buy	+1,200	New	+$121K	﹤0.01%	1205

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Vontobel Holding's BNTX Position: Q2 2026 in Review

Vontobel Holding reduced its BioNTech (BNTX) stake by 34% in Q2 2026, selling an estimated $3M and leaving 61,238 shares worth $5.7M. The position accounts for 0.02% of the portfolio, ranked #427.

Vontobel Holding first reported a position in BNTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $14.9M in Q1 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Vontobel Holding held 61,238 shares of BioNTech worth $5.7M as of Q2 2026.
Vontobel Holding sold 31,869 BioNTech shares in Q2 2026, an estimated $3M.
BioNTech made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #427 holding.
Vontobel Holding first reported a position in BioNTech in Q2 2022 and has held it in 17 quarters since.
Vontobel Holding's BioNTech position peaked at $14.9M in Q1 2023.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.